• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transport and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
Hogan Lovells Engage 5.7.7
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transport and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
  1. News
  2. FSIS issues final rule expanding generic label approval

FSIS issues final rule expanding generic label approval

18 January 2023
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Get link
    • Get QR Code
    • Download
    • Print

The U.S. Food Safety and Inspection Service (FSIS) recently issued a final rule expanding the circumstances under which it will generically approve the labels of meat, poultry, and egg products. As a result of the expansion, which takes effect March 20, 2023, establishments will be able to lawfully market an even wider variety of meat, poultry, and egg products without submitting product labels to FSIS for prior sketch approval.

Index
  1. Background
    1. New Labeling Claims Eligible for Generic Approval

Background

Under FSIS’s label approval regulations, certain categories of product labels must be submitted to the agency for “sketch approval” prior to use. Other categories of product labels are considered “generically approved” and may therefore be used without prior FSIS review, so long as they comply with the agency’s labeling regulations. This marks the third time FSIS has expanded the categories of labeling claims eligible for generic approval since the concept was first introduced in the 1980s.

New Labeling Claims Eligible for Generic Approval

The same general framework for label approval will remain in place, but the final rule1 modifies the framework such that the labels of the following types of products are now eligible for generic approval:

  • Products only intended for export that deviate from domestic labeling requirements;
  • Products that receive voluntary FSIS inspection; and
  • Products bearing the following special statements and claims:
    • “Organic” claims that appear in a product label’s ingredient statement, which designate an ingredient (but not the product as a whole2) as certified “organic” under the Agricultural Marketing Service’s (AMS’s) National Organic Program;
    • “Geographic landmarks” displayed on a product label, such as a foreign country’s flag, monument, or map; and
    • “Negative” claims made on product labels that identify the absence of certain ingredients or types of ingredients, such as “No MSG Added,” “Preservative Free,” or “Made Without Soy” (excluding claims related to the raising of the animal from which the product is derived or negative claims related to the use of genetically modified ingredients).

The final rule also states that FSIS will no longer evaluate generically approved labels submitted voluntarily to the agency for review. Other generic labeling resources will continue to be available to the industry, including FSIS’s updated generic label approval compliance guideline.3

* * *

We will continue to monitor changes to FSIS’s label approval program. Please do not hesitate to reach out about this or any other matter.

 

 

Authored by Brian Eyink and Rachel Buff.

References
1 88 Fed. Reg. 2798 (Jan. 18, 2023), available at: https://www.federalregister.gov/documents/2023/01/18/2023-00693/prior-label-approval-system-expansion-of-generic-label-approval.
2 FSIS will continue to require sketch approval for claims that the product as a whole is organic.
3 Guideline for Label Approval, FSIS (Jan. 2023), available at: https://www.fsis.usda.gov/guidelines/2023-0001.
Contacts
Brian Eyink
Partner
Washington, D.C.
Rachel Buff
Associate
Washington, D.C.
Index
  1. Background
    1. New Labeling Claims Eligible for Generic Approval
Related Materials
Sanctions Navigator

Sanctions Navigator: Russia Sanctions

shutterstock_239870086

FTC seeks to reinvigorate enforcement of Robinson-Patman Act

GO-food law-bottle-shutterstock_64088218

OMB releases Fall 2022 Unified Agenda of Regulatory Actions

shutterstock_734579047

Cannabis legal in Germany in 2023? Potential requirements for production, distribution and trade

Keywords FSIS, generic label approval, meat, poultry, egg
Languages English
Topics Food Legislation and Regulatory Policy Development, Food Labeling, Food Advertising and Claims Substantiation
Countries United States
Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content

  • Contact us
  • Disclaimer
  • Privacy
  • Cookies
  • Legal Notices
  • Terms of Use

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2022 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.

Thomson Reuters HighQ Logo
© 2023 Hogan Lovells | Privacy Policy | Terms of Service